Search Results - "Bull, Rowena A."

Refine Results
  1. 1

    Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission by Shrestha, Lok Bahadur, Foster, Charles, Rawlinson, William, Tedla, Nicodemus, Bull, Rowena A.

    Published in Reviews in medical virology (01-09-2022)
    “…The first dominant SARS‐CoV‐2 Omicron variant BA.1 harbours 35 mutations in its Spike protein from the original SARS‐CoV‐2 variant that emerged late 2019. Soon…”
    Get full text
    Journal Article
  2. 2

    Broadly-Neutralizing Antibodies Against Emerging SARS-CoV-2 Variants by Shrestha, Lok Bahadur, Tedla, Nicodemus, Bull, Rowena A.

    Published in Frontiers in immunology (27-09-2021)
    “…The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants have become a major concern in the containment of current pandemic. The…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Rapid evolution of pandemic noroviruses of the GII.4 lineage by Bull, Rowena A, Eden, John-Sebastian, Rawlinson, William D, White, Peter A

    Published in PLoS pathogens (01-03-2010)
    “…Over the last fifteen years there have been five pandemics of norovirus (NoV) associated gastroenteritis, and the period of stasis between each pandemic has…”
    Get full text
    Journal Article
  5. 5

    The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry by Narayana, Sumudu K., Helbig, Karla J., McCartney, Erin M., Eyre, Nicholas S., Bull, Rowena A., Eltahla, Auda, Lloyd, Andrew R., Beard, Michael R.

    Published in The Journal of biological chemistry (23-10-2015)
    “…The interferon-induced transmembrane (IFITM) family of proteins have recently been identified as important host effector molecules of the type I interferon…”
    Get full text
    Journal Article
  6. 6

    Norovirus recombination by Bull, Rowena A, Tanaka, Mark M, White, Peter A

    Published in Journal of general virology (01-12-2007)
    “…School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney 2052, Australia Correspondence Peter A. White…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection by Bull, Rowena A, Luciani, Fabio, McElroy, Kerensa, Gaudieri, Silvana, Pham, Son T, Chopra, Abha, Cameron, Barbara, Maher, Lisa, Dore, Gregory J, White, Peter A, Lloyd, Andrew R

    Published in PLoS pathogens (01-09-2011)
    “…Hepatitis C is a pandemic human RNA virus, which commonly causes chronic infection and liver disease. The characterization of viral populations that…”
    Get full text
    Journal Article
  10. 10

    Viral quasispecies assembly via maximal clique enumeration by Töpfer, Armin, Marschall, Tobias, Bull, Rowena A, Luciani, Fabio, Schönhuth, Alexander, Beerenwinkel, Niko

    Published in PLoS computational biology (01-03-2014)
    “…Virus populations can display high genetic diversity within individual hosts. The intra-host collection of viral haplotypes, called viral quasispecies, is an…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance by Eltahla, Auda A, Luciani, Fabio, White, Peter A, Lloyd, Andrew R, Bull, Rowena A

    Published in Viruses (29-09-2015)
    “…The hepatitis C virus (HCV) is a pandemic human pathogen posing a substantial health and economic burden in both developing and developed countries…”
    Get full text
    Journal Article Book Review
  15. 15

    Contribution of Intra- and Interhost Dynamics to Norovirus Evolution by BULL, Rowena A, EDEN, John-Sebastian, LUCIANI, Fabio, MCELROY, Kerensa, RAWLINSON, William D, WHITE, Peter A

    Published in Journal of Virology (01-03-2012)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  16. 16

    Genome-Wide Mutagenesis of Dengue Virus Reveals Plasticity of the NS1 Protein and Enables Generation of Infectious Tagged Reporter Viruses by Eyre, Nicholas S, Johnson, Stephen M, Eltahla, Auda A, Aloi, Maria, Aloia, Amanda L, McDevitt, Christopher A, Bull, Rowena A, Beard, Michael R

    Published in Journal of virology (01-12-2017)
    “…Dengue virus (DENV) is a major global pathogen that causes significant morbidity and mortality in tropical and subtropical areas worldwide. An improved…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A method for near full-length amplification and sequencing for six hepatitis C virus genotypes by Bull, Rowena A, Eltahla, Auda A, Rodrigo, Chaturaka, Koekkoek, Sylvie M, Walker, Melanie, Pirozyan, Mehdi R, Betz-Stablein, Brigid, Toepfer, Armin, Laird, Melissa, Oh, Steve, Heiner, Cheryl, Maher, Lisa, Schinkel, Janke, Lloyd, Andrew R, Luciani, Fabio

    Published in BMC genomics (17-03-2016)
    “…Hepatitis C virus (HCV) is a rapidly evolving RNA virus that has been classified into seven genotypes. All HCV genotypes cause chronic hepatitis, which…”
    Get full text
    Journal Article
  19. 19

    Conserved epitopes with high HLA-I population coverage are targets of CD8+ T cells associated with high IFN-γ responses against all dengue virus serotypes by Adikari, Thiruni N., Di Giallonardo, Francesca, Leung, Preston, Grifoni, Alba, Sette, Alex, Weiskopf, Daniela, Bull, Rowena A., Luciani, Fabio

    Published in Scientific reports (24-11-2020)
    “…Cytotoxic CD8 + T cells are key for immune protection against viral infections. The breadth and cross-reactivity of these responses are important against…”
    Get full text
    Journal Article
  20. 20

    Hepatitis C Virus Epitope Immunodominance and B Cell Repertoire Diversity by Brasher, Nicholas A, Adhikari, Anurag, Lloyd, Andrew R, Tedla, Nicodemus, Bull, Rowena A

    Published in Viruses (25-05-2021)
    “…Despite the advent of effective, curative treatments for hepatitis C virus (HCV), a preventative vaccine remains essential for the global elimination of HCV…”
    Get full text
    Journal Article